Health
-
Hope for sufferers of ‘invisible’ tinnitus disorder
Researchers develop way to objectively measure common malady, which may improve diagnosis, help in developing therapies
-
What your brain score says about your body
Simple tool can be used to identify risk factors for cancer and heart disease too, says new study
-
Son’s diabetes diagnosis sent scientist on quest for cure
Decades later, Doug Melton and team are testing treatment that could make insulin shots obsolete
-
Wildfire smoke can harm heart and lungs even after the fire has ended
First study to fully assess its impact on all major types of cardiovascular, respiratory diseases
-
Young researcher’s ALS attack plan is now a no-go
Career award among casualties of ‘terrifying’ cuts affecting lab of David Sinclair
-
Miracle drugs don’t come out of nowhere
Healthcare, innovation experts say funding cuts to university labs will slow or stop basic research on which breakthroughs are built
-
New hope for treating ALS
Harvard stem cell scientists have discovered that a recently approved medication for epilepsy might be a meaningful treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, a uniformly fatal neurodegenerative disorder.
-
A healthy replacement for dieting
Three specialists spoke to students about the benefits of intuitive eating in an event at Sever Hall.
-
Microscopic particles carry big concerns
With a growing concern about nanoparticle use in everyday objects, scientists at the Harvard School of Public Health have discovered a fast, simple, and inexpensive method to measure the effective density of engineered nanoparticles, making it possible to accurately determine the amount that comes into contact with cells and tissue.
-
A face is not a fish
A new study from Dartmouth and Harvard researchers looks at the mechanisms behind facial recognition.
-
Solving the problem of shape-shifters
Investigators at Harvard-affiliated Massachusetts General Hospital (MGH) may have found a way to solve a problem that has plagued ligand-mimicking integrin inhibitors, a group of drugs that have the potential to treat conditions ranging from heart attacks to cancer metastasis.
-
New childhood TB cases double earlier estimates
Harvard researchers have estimated that around 1 million children suffer from tuberculosis annually — twice the number previously thought to have the disease and three times the number of cases diagnosed every year.
-
Fair-minded birds
New research conducted at Harvard demonstrates sharing behavior in African grey parrots.
-
Genetic link between fried foods and obesity?
Harvard researchers have released the first study to show that the adverse effects of fried foods may vary depending on the genetic makeup of the individual.
-
Too sweet for our own good
Even the “healthy” fruit drinks that Americans sip are packed with the amount of sugar contained in six cookies. That love affair is making us sick.
-
Secrets of the narwhal tusk
The narwhal tusk has now been mapped, showing a pathway between the spiral tooth and the narwhal brain. The study reflects how the mysterious animal may use its tusk to suss out its environment.
-
Imbalance in microbial population found in Crohn’s patients
A multi-institutional study led by investigators from Massachusetts General Hospital and the Broad Institute of Harvard and MIT reports that newly diagnosed Crohn’s disease patients show increased levels of harmful bacteria and reduced levels of the beneficial bacteria usually found in a healthy gastrointestinal tract.
-
Toward an AIDS-free generation
AIDS researchers and medical ethicists gathered at the Harvard School of Public Health to explore possible ethical issues affecting studies of promising strategies to fight the ailment.
-
Key connection
Scientists have long suggested that the best way to settle the debate about how phenotypic plasticity may be connected to evolution would be to identify a mechanism that controls both. Harvard researchers say they have discovered just such a mechanism in insulin signaling in fruit flies.
-
Vaccine holds promise against ovarian cancer
A novel approach to cancer immunotherapy — strategies designed to induce the immune system to attack cancer cells — may provide a new and cost-effective weapon against some of the most deadly tumors, including ovarian cancer and mesothelioma.
-
Quality control
A Harvard research team led by Kevin Kit Parker, a Harvard Stem Cell Institute principal faculty member, has identified a set of 64 crucial parameters by which to judge stem cell-derived cardiac myocytes, making it possible for scientists and pharmaceutical companies to quantitatively judge and compare the value of stem cells.
-
Alzheimer’s in a dish
Harvard stem cell scientists have successfully converted skins cells from patients with early onset Alzheimer’s into the types of neurons affected by the disease, making it possible for the first time to study this leading form of dementia in living human cells.
-
Study shows kids eating more fruits, veggies
A Harvard School of Public Health study has found that new federal standards launched in 2012 that require schools to offer healthier meals have led to more fruit and vegetable consumption. This contradicts criticisms that the new standards have increased food waste.
-
Major step in preventing type 2 diabetes
Researchers at the Broad Institute and Massachusetts General Hospital, both Harvard affiliates, have identified mutations in a gene that can reduce the risk of individuals developing type 2 diabetes. If a drug can be developed that mimics the protective effect of these mutations, it could open up new ways of preventing this devastating disease.
-
High-calorie feeding may slow progression of ALS
In a small study by Harvard-affiliated Massachusetts General Hospital, increasing the number of calories consumed by patients with amyotrophic lateral sclerosis (ALS) may be a relatively simple way of extending their survival.
-
How Earth was watered
Evidence is mounting that Earth’s water arrived during formation, aboard meteorites and small bodies called “planetesimals.”
-
Lessening liver damage
Harvard stem cell scientists studying the effect of nitric oxide on liver growth and regeneration appear to have serendipitously discovered a markedly improved treatment for liver damage caused by acetaminophen toxicity.
-
Toxic chemicals linked to brain disorders in children
Toxic chemicals may be triggering recent increases in neurodevelopmental disabilities among children — such as autism, attention-deficit hyperactivity disorder, and dyslexia — according to a new study. The researchers say a new global prevention strategy to control the use of these substances is urgently needed.
-
Evolution in real time
After 26 years of workdays spent watching bacteria multiply, Richard Lenski has learned that evolution doesn’t always occur in steps so slow and steady that change can’t be observed.
-
At the Arboretum, an unquiet winter
Despite the dormant appearance of the trees, the Arnold Arboretum isn’t waiting for spring, as pruning, mowing, research, and planning continue to move ahead at full speed.
-
The threat from superbugs
Hospital stewardship programs, community education, and legal changes to allow pharmaceutical companies to profit longer from new antibiotics are among reforms that experts suggest to fight drug-resistant bacteria.
-
Nutritional supplement slows onset of Huntington’s
The first clinical trial of a drug intended to delay the onset of symptoms of Huntington’s disease (HD) reveals that high-dose treatment with the nutritional supplement creatine was safe and well tolerated by most study participants. Neuroimaging also showed a treatment-associated slowing of regional brain atrophy, evidence that creatine might slow the progression of presymptomatic HD.
-
Study ties fetal sex to milk production
A new study offers the first evidence that fetal sex can affect the amount of milk cows produce, a finding that could have major economic implications for dairy farmers.
-
‘On’ switches for cells
Scientists at Harvard have identified a previously unknown embryonic signal, dubbed Toddler, that instructs cells to move and reorganize themselves, through a process known as gastrulation, into three layers.
-
Neanderthals’ DNA legacy linked to modern ailments
Remnants of Neanderthal DNA in modern humans are associated with genes affecting type 2 diabetes, Crohn’s disease, lupus, biliary cirrhosis, and smoking behavior. They also concentrate in genes that influence skin and hair characteristics. At the same time, Neanderthal DNA is conspicuously low in regions of the X chromosome and testes-specific genes.
-
Researchers create embryonic stem cells without embryo
Researchers have created embryonic stem cells without an embryo. This discovery of a novel reprogramming method of adult cells, without introducing external genetic material, could dramatically shift stem cell research.